TURA classification in chronic myeloid leukemia - Lath William, Edjeme Gnagneli
40,99 €
inkl. MwSt.
Versandkostenfrei*
Versandfertig in über 4 Wochen
  • Broschiertes Buch

Our retrospective and prospective study on the impact of the TURA classification on prognosis and survival in CML was carried out on a sample of 52 patients collected in the clinical haematology department of the Yopougon University Hospital over a 19-year period (1989 to 2008): Concerning the therapeutic response: In terms of haematological response and in a non-significant way, (P = 0,155) we observed a higher number of haematological response for the intermediate prognosis, i.e. 27 cases, against 2 cases for the good prognosis and 9 cases for the bad prognosis. Concerning the outcome: The…mehr

Andere Kunden interessierten sich auch für
Produktbeschreibung
Our retrospective and prospective study on the impact of the TURA classification on prognosis and survival in CML was carried out on a sample of 52 patients collected in the clinical haematology department of the Yopougon University Hospital over a 19-year period (1989 to 2008): Concerning the therapeutic response: In terms of haematological response and in a non-significant way, (P = 0,155) we observed a higher number of haematological response for the intermediate prognosis, i.e. 27 cases, against 2 cases for the good prognosis and 9 cases for the bad prognosis. Concerning the outcome: The number of deaths was low but not significantly (p = 0.122) with the TURA classification. We observed 7 cases of death for the intermediate prognosis, 7 cases for the poor prognosis and 0 cases for the good prognosis. Concerning survival, there was a significant difference in terms of median survival in the three groups p = 0.057. Thus, for the good prognosis group, the median survival was 40 months, whereas for the intermediate and poor prognosis groups, the median survival was 40 months.
Autorenporträt
EDJEME Gnagneli lath William Doutor em Medicina tendo obtido o seu Doutoramento de Estado em Medicina na Faculdade de Medicina de Farmácia e Odontostomatologia de Bamako no Mali em Abril de 2008, Titular de um Mestrado I em saúde pública opção saúde pública e desenvolvimento; este foi feito para: Identificar as características epidemiológicas.